BioMOBIUS™ Research Platform Allows Sophisticated Technology Solutions for Biomedical Research

TRIL (Technology Research for Independent Living) CentreTRIL (Technology Research for Independent Living) Centre launched the BioMOBIUS™ Research Platform, an open shareable technology platform, which allows researcher to rapidly develop sophisticated technology solutions for biomedical research. This platform helps researchers to reduce the time spent on developing foundational technologies, allowing them to focus on their actual research.

The software elements of BioMOBIUS™ provide:

  • Rapid Development (Graphical Development Environment)
  • Biosignal Processing Applications (Real Time)
  • Mobile hardware and physiological sensor support
  • Straightforward user interfaces (GUI Designer)
  • Reduced Development Replication (Re-use of Blocks)
  • Targeting applications

The BioMOBIUS Research Platform was developed by the TRIL Centre, a groundbreaking research collaboration between Intel Corporation and a number of Irish academic partners, and jointly funded by Intel and the Industrial Development Agency (IDA) Ireland. Its goal is to explore technology to help older people to continue living independently. The platform is being used primarily by TRIL researchers to help clinicians detect and prevent or alleviate certain conditions related to ageing, such as falls and cognitive decline, and to help older people to strengthen their social connections.

The hardware elements of the BioMOBIUS™ research platform provide support for the SHIMMER wireless sensor platform and other third party hardware and sensor devices.

BioMOBIUS™ is freely available to users for research purposes only. Please follow the links to the register and download pages to obtain a copy of the BioMOBIUS™ software environment. Details on hardware support and availability can be found in the hardware section. Please feel to share your experiences of MOBIUS and suggestions for enhancements and new features via the provided discussion forum.

For further information, please visit:
http://biomobius.trilcentre.org

Related news articles:

About the TRIL Centre
The TRIL Centre is a multi-million euro research collaboration between industry and academic partners including Intel, University College Dublin, Trinity College Dublin and the National University of Ireland, Galway. The Centre has created dedicated laboratories at Intel and in each of the universities involved, and is driving bi-directional knowledge and technology transfer of research that addresses the physical, cognitive and social consequences of ageing. The TRIL Centre is one of the largest research projects of its kind in the world. It will develop innovative technologies to help people 'age in place' wherever they choose to live. For more information, please visit www.trilcentre.org.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...